CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 9 years ago You may also like 1:00:48 Dystrophin 101 Webinar (March 2015) 10 years ago Research & Clinical Trial Webinars,Webinars 1:01:10 Combination Therapies Webinar (December 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:01:31 Duchenne Pulmonary Care for Adults Webinar (November 2014) 10 years ago Care Webinars,Webinars 55:34 Middle Pulmonary Care Webinar (October 2014) 10 years ago Care Webinars,Webinars 47:50 Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:07:03 Prosensa Update about Drisapersen & Other Programs (October 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:05:45 Early Pulmonary Care Webinar (September 2014) 10 years ago Care Webinars,Webinars 41:57 Translarna™ (ataluren) update (June 2014) 10 years ago Research & Clinical Trial Webinars,Webinars «1…202122232425»Page 22 of 25
by: Parent Project Muscular Dystrophy
